Pluta Ryszard M, Dejam Andre, Grimes George, Gladwin Mark T, Oldfield Edward H
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md 20892, USA.
JAMA. 2005 Mar 23;293(12):1477-84. doi: 10.1001/jama.293.12.1477.
Delayed cerebral vasospasm causes permanent neurological deficits or death in at least 15% of patients following otherwise successful treatment for ruptured intracranial aneurysm. Decreased bioavailability of nitric oxide has been associated with the development of cerebral vasospasm.
To determine whether infusions of nitrite will prevent delayed cerebral vasospasm.
DESIGN, SETTING, AND SUBJECTS: A total of 14 anesthetized cynomolgus monkeys had an autologous blood clot placed around the right middle cerebral artery. Cerebral arteriography was performed before clot placement and on days 7 and 14 to assess vasospasm. The study was conducted from August 2003 to February 2004.
A 90-mg sodium nitrite intravenous solution infused over 24 hours plus a 45-mg sodium nitrite bolus daily (n = 3); a 180-mg sodium nitrite intravenous solution infused over 24 hours (n = 3); or a control saline solution infusion (n = 8). Each was infused continuously for 14 days.
Nitrite, S-nitrosothiol, and methemoglobin levels in blood and cerebrospinal fluid and degree of arteriographic vasospasm.
In control monkeys, mean (SD) cerebrospinal fluid nitrite levels decreased from 3.1 (1.5) micromol/L to 0.4 (0.1) micromol/L at day 7 and to 0.4 (0.4) micromol/L at day 14 (P = .03). All 8 control monkeys developed significant vasospasm of the right middle cerebral artery, which was complicated by stroke and death in 1 animal. Sodium nitrite infusions increased the nitrite and methemoglobin levels (<2.1% of total hemoglobin) in the blood and cerebrospinal fluid without evoking systemic hypotension. Nitrite infusion prevented development of vasospasm (no animals developed significant vasospasm; mean [SD] reduction in right middle cerebral artery area on day 7 after subarachnoid hemorrhage of 8% [9%] in nitrite-treated monkeys vs 47% [5%] in saline-treated controls; P<.001). There was a negative correlation between the concentration of nitrite in cerebrospinal fluid and the degree of cerebral vasospasm (P<.001). Pharmacological effects of nitrite infusion were also associated with the formation of S-nitrosothiol in cerebrospinal fluid. There was no clinical or pathological evidence of nitrite toxicity.
Subacute sodium nitrite infusions prevented delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage.
在颅内动脉瘤破裂后经其他成功治疗的患者中,至少15%会因迟发性脑血管痉挛导致永久性神经功能缺损或死亡。一氧化氮生物利用度降低与脑血管痉挛的发生有关。
确定输注亚硝酸盐是否能预防迟发性脑血管痉挛。
设计、设置和研究对象:总共14只麻醉的食蟹猴,在右侧大脑中动脉周围放置自体血凝块。在放置血凝块前以及第7天和第14天进行脑血管造影以评估血管痉挛情况。该研究于2003年8月至2004年2月进行。
24小时内静脉输注90毫克亚硝酸钠溶液加每日45毫克亚硝酸钠推注(n = 3);24小时内静脉输注180毫克亚硝酸钠溶液(n = 3);或输注对照生理盐水溶液(n = 8)。每种溶液持续输注14天。
血液和脑脊液中亚硝酸盐、S-亚硝基硫醇和高铁血红蛋白水平以及血管造影血管痉挛程度。
在对照猴中,脑脊液中亚硝酸盐平均(标准差)水平在第7天从3.1(1.5)微摩尔/升降至0.4(0.1)微摩尔/升,在第14天降至0.4(0.4)微摩尔/升(P = 0.03)。所有8只对照猴均出现右侧大脑中动脉显著血管痉挛,其中1只动物并发中风和死亡。输注亚硝酸钠可提高血液和脑脊液中亚硝酸盐和高铁血红蛋白水平(<总血红蛋白量的2.1%),且未引起全身性低血压。输注亚硝酸盐可预防血管痉挛的发生(无动物出现显著血管痉挛;蛛网膜下腔出血后第7天,亚硝酸钠治疗组猴右侧大脑中动脉面积平均[标准差]减少8%[9%],而生理盐水治疗对照组为47%[5%];P<0.001)。脑脊液中亚硝酸盐浓度与脑血管痉挛程度呈负相关(P<0.001)。输注亚硝酸盐的药理作用还与脑脊液中S-亚硝基硫醇的形成有关。没有亚硝酸盐毒性的临床或病理证据。
在蛛网膜下腔出血的灵长类动物模型中,亚急性输注亚硝酸钠可预防迟发性脑血管痉挛。